5Y3L image
Deposition Date 2017-07-29
Release Date 2018-04-18
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5Y3L
Keywords:
Title:
Crystal structure of horse TLR9 in complex with two DNAs (CpG DNA and CCGCAC DNA)
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Toll-like receptor 9
Gene (Uniprot):TLR9
Chain IDs:A, D (auth: B)
Chain Length:802
Number of Molecules:2
Biological Source:Equus caballus
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*AP*GP*GP*CP*GP*TP*TP*TP*TP*T)-3')
Chain IDs:B (auth: C), E (auth: D)
Chain Length:10
Number of Molecules:2
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*CP*CP*GP*CP*AP*C)-3')
Chain IDs:C (auth: E), F
Chain Length:6
Number of Molecules:2
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Toll-like Receptor 9 Contains Two DNA Binding Sites that Function Cooperatively to Promote Receptor Dimerization and Activation
Immunity 48 649 658.e4 (2018)
PMID: 29625894 DOI: 10.1016/j.immuni.2018.03.013

Abstact

Toll-like receptor 9 (TLR9) recognizes DNA containing CpG motifs derived from bacteria and viruses and activates the innate immune response to eliminate them. TLR9 is known to bind to CpG DNA, and here, we identified another DNA binding site in TLR9 that binds DNA containing cytosine at the second position from the 5' end (5'-xCx DNA). 5'-xCx DNAs bound to TLR9 in the presence of CpG DNA and cooperatively promoted dimerization and activation of TLR9. Binding at both sites was important for efficient activation of TLR9. The 5'-xCx DNA bound the site corresponding to the nucleoside binding site in TLR7 and TLR8 as revealed by the structural analysis. This study revealed that TLR9 recognizes two types of DNA through its two binding sites for efficient activation. This information may contribute to the development of drugs that control the activity of TLR9.

Legend

Protein

Chemical

Disease

Primary Citation of related structures